oral glp-1 medications New drug delivers up to 12% weight loss in 36 weeks Eli Lilly's Oral GLP-1 Therapy
Description
It is not intended for human or animal consumption, diagnosis, or treatment
Another study evaluating cardiovascular outcomes of GLP-1RAs was the HARMONY study
For people with type 2 diabetes and a BMI over 27, part of the cost is covered by Kela, the Finnish social insurance institution
The goal isnt simply helping people lose weight, he said
